UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November 7, 2011
Date of Report (Date of earliest event reported)
Medytox Solutions, Inc.
(Exact name of registrant as specified in its charter)
Nevada
(State or Other Jurisdiction of Incorporation)
000-54346
(Commission File Number)
54-2156042
(IRS Employer Identification No.)
400 S. Australian Ave., Suite 800, West Palm Beach, Florida 33401
(Address of Principal Executive Offices and Zip Code)
(561) 855-1626
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[__] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[__] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[__] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[__] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)
Section 4 Matters Related to Accountants and Financial Statements
Item 4.01 Changes in Registrant's Certifying Accountant.
(1) Previous Independent Auditors:
a. Our independent auditor, Mr. Malcolm L. Pollard ("Pollard") of Malcom L.
Pollard, Inc. has resigned due to his retirement from his accounting practice
on October 31, 2011 and advised us on October 15, 2011 that he would not
provide any further audit services to our company. Mr. Pollard's report on the
financial statements for the year ended December 31, 2010 contained no adverse
opinion or disclaimer of opinion and was not qualified or modified as to
uncertainty, audit scope or accounting principles except to include an
explanatory paragraph expressing substantial doubt as to the Company's ability
to continue as a going concern.
b. Through the period covering the financial audits for December 31, 2009
and 2010 and any subsequent interim period through the date of retirement,
there have been no disagreements with Pollard on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope or
procedure, which disagreements if not resolved to the satisfaction of Pollard
would have caused him to make reference thereto in his report on the financial
statements. Pollard's report on the financial statements for the year ended
December 31, 2010 contained no adverse opinion or disclaimer of opinion and
was not qualified or modified as to uncertainty, audit scope or accounting
principles.
c. During the most recent review periods, subsequent to December 31, 2010,
there have been no reportable events with us as set forth in Item 304(a)(1)(v)
of Regulation S-K.
d. We have requested that Pollard furnish us with a letter addressed to the
SEC stating whether or not he agrees with the above statements.
(2) New Independent Accountants:
a. Subsequent to Pollard's retirement on October 31, 2011, we solicited the
services of Peter Messineo, CPA, to serve as our independent registered
auditor. We engaged Peter Messineo, CPA, of Palm Harbor, Florida, as our new
independent registered auditor on November 1, 2011.
b. Prior to November 1, 2011, we did not consult with Peter Messineo, CPA
regarding (i) the application of accounting principles, (ii) the type of audit
opinion that might be rendered by Peter Messineo, CPA or (iii) any other
matter that was the subject of a disagreement between us and our former
auditor or was a reportable event (as described in Items 304(a)(1)(iv) or Item
304(a)(1)(v) of Regulation S-B, respectively).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDYTOX SOLUTIONS, INC.
DATED: November 7, 2011. By: /s/: William G. Forhan
William G. Forhan, CEO, CFO and Chairman,
(Principal Executive Officer)
(Principal Financial and Accounting Officer)
3
